BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, May 2, 2024
See today's BioWorld MedTech
Home
» Strong year for med-tech M&As; digital health prevails
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Strong year for med-tech M&As; digital health prevails
Sep. 17, 2021
By
Karen Carey
No Comments
With one completed med-tech merger ranking within the
BioWorld
Top 10 list for highest value, and two others set to join the list in coming months, 2021 is turning out to be the strongest M&A year for the industry to date.
BioWorld MedTech
Analysis and data insight
Deals and M&A